Introduction: COVID-19 is a systemic disease; the lungs are most commonly affected, with histopathological findings that may include diffuse alveolar epithelium destruction, capillary damage or bleeding, hyaline membrane formation, alveolar septal fibrous proliferation, and pulmonary consolidation. Method: This study was designed as experimental, randomized double-blinded study. Participate divided into two groups- the pulmonary rehabilitation group(Group A) and control group(Group B). The inclusion criteria were patient with confirmed case of infection of COVID-19 was defined by RT-PCR assay on nasopharyngeal swab; aged 20 to 55 years; Hospitalised due to severity of covid-19 symptoms, persistent high grade fever>1000 F, breathlessness, increase in dry cough), ≥3 months after any hospital discharge related to COVID-19 infection, regardless of need for critical care or ventilator support., Any persistent sequel of COVID- 19. All participants were explained the study protocol and they were enrolled in protocol after their written consent for this study. 6 minute walk test (6 MWT) was taken before and after the study protocol. Within group analysis using Wilcoxon signed Rank test. Between group analysis using Mann-Whitney Test. Level of significance was kept at p<0.005. Results: Within group analysis showed statistically significant difference in Group A (Z=-5.076,p=0.0001) whereas no statistically difference in Group B (Z=-2.160 ,p=0.078). Comparison of end of 8 weeks intervention data which shows that there is statistically significant difference in both the groups(U=45, p =0.001) Conclusion: Pulmonary rehabilitation is possible and effective therapeutic strategy to improve the aerobic capacity and improve quality of life post-hospitalized COVID-19 patients. Keywords: COVID-19, Pulmonary Rehabilitation, Aerobic capacity

Introduction: COVID-19 is a serious disease that can significantly affect the daily lives of recovered patients and their families in terms of mental health problems such as stress, depression, anxiety and insomnia, as well as the negative impact COVID-19 has on patients’ quality of life (QoL). Since the patients are not immune to future infection, it may lead to a more negative impact on patients’ QoL. The survey was conducted to assess the quality of life in patients with any sequelae after covid19. Methodology: 102 confirmed patients of post COVID-19 (by RT-PCR assay on nasopharyngeal swab) were selected by convenience sampling. An observational study was conducted using Google self-designed Questionnaire. Participants were selected according to inclusion criteria which included any one sequelae after COVID-19. Quality of life of the participants was taken by SF-12. Questionnaire was circulated in different groups via WhatsApp. The questionnaire took 5-10 minutes to complete. Descriptive analysis was done in Microsoft excel. Results: The participants mean age was 34.63 11.92 years, with 69 male and 34 female patients were evaluated. In present study physical score is 46.9(PCS) and mental score is 47.9(MCS). Conclusion: Moderate affection of physically and mentally in patients of who were infected with COVID-19.so, the quality of life affected in patients with sequelae of after COVID-19. Keywords: COVID- 19, Quality of life, Physical health, Mental health